Philip Houska Apple's health initiative is gaining momentum again. The Californian company expanded its ranks with the American startup Gliimpse, which specializes in collecting and sharing health data. The acquisition took place according to Fast Company already at the beginning of this year, but no one has informed about it yet. The amount Apple spent is also unknown.
Gliimpse, originally from Silicon Valley, focuses on the sphere of modern healthcare, especially on the issues of type 1 diabetes and cancer. It collects health data from users from other platforms and uses its technology to summarize this information into a single document. Just such a record can be shared with selected doctors or become part of a "national health chart" to which those concerned anonymously contribute their data. These can be used, for example, for various medical researches.
This startup can be a valuable addition to Apple's health platform portfolio. It currently has HealthKit packages, ResearchKit a CareKit, which are taking important steps to make Apple an even stronger and more revolutionary player in the field of medicine.
The California firm commented on the latest acquisition with the traditional words that "from time to time we buy small technology companies, but we generally do not discuss our intentions".
